tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMGN Stock Latest News

Amgen Advances Early-Stage Obesity Candidate With New Injection Trial
Company AnnouncementsAmgen Advances Early-Stage Obesity Candidate With New Injection Trial
7h ago
AMGN
Amgen assumed at Buy from Neutral at UBS
PremiumThe Fly
Amgen assumed at Buy from Neutral at UBS
1d ago
AMGN
Amgen upgraded to Buy from Neutral at UBS
PremiumThe Fly
Amgen upgraded to Buy from Neutral at UBS
1d ago
AMGN
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
1d ago
F
AMD
M&A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue
PremiumMarket News
M&A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue
1d ago
AMGN
Amgen acquires Dark Blue Therapeutics in deal valued at up to $840M
PremiumThe FlyAmgen acquires Dark Blue Therapeutics in deal valued at up to $840M
1d ago
AMGN
MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
Premium
Market News
MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
15d ago
AZN
CRM
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease
Premium
Company Announcements
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease
16d ago
AMGN
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors
PremiumCompany Announcements
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors
16d ago
AMGN
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
PremiumThe Fly
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
16d ago
CI
BMY
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
PremiumMarket News
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
17d ago
CI
CL
Trump announces pacts with nine pharma companies to lower drug prices
PremiumThe Fly
Trump announces pacts with nine pharma companies to lower drug prices
19d ago
BMY
GSK
Amgen reaches pact with U.S. to reduce drug costs
PremiumThe FlyAmgen reaches pact with U.S. to reduce drug costs
19d ago
AMGN
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a)
Premium
Company Announcements
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a)
19d ago
AMGN
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
Premium
Market News
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
21d ago
AZN
CRM
Amgen call volume above normal and directionally bullish
PremiumThe Fly
Amgen call volume above normal and directionally bullish
23d ago
AMGN
Amgen’s New Phase 3 Trial: A Potential Game-Changer for Obstructive Sleep Apnea Treatment
PremiumCompany Announcements
Amgen’s New Phase 3 Trial: A Potential Game-Changer for Obstructive Sleep Apnea Treatment
24d ago
AMGN
Amgen’s New Study on Maridebart Cafraglutide: A Potential Game-Changer in Obesity Treatment?
PremiumCompany Announcements
Amgen’s New Study on Maridebart Cafraglutide: A Potential Game-Changer in Obesity Treatment?
24d ago
AMGN
Amgen treatment of acute lymphoblastic leukemia granted orphan status
PremiumThe Fly
Amgen treatment of acute lymphoblastic leukemia granted orphan status
26d ago
AMGN
Amgen price target lowered to $304 from $329 at Morgan Stanley
PremiumThe FlyAmgen price target lowered to $304 from $329 at Morgan Stanley
26d ago
AMGN
FDA approves Amgen’s Uplinza for treatment of generalized myasthenia gravis
Premium
The Fly
FDA approves Amgen’s Uplinza for treatment of generalized myasthenia gravis
27d ago
AMGN
Amgen approves UPLIZNA for treatment of generalized myasthenia gravis
Premium
The Fly
Amgen approves UPLIZNA for treatment of generalized myasthenia gravis
27d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >